Bank of New York Mellon »

Ptc Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Ptc Therapeutics shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Ptc Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-06-30 $326k 200k 1.63

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Micron Technology (MU)
Meta Platforms Inc-class A Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Ptc Therapeutics

Franklin Resources
Tenor Capital Management
Capstone Investment Advisors
OZ Management
DeepCurrents Investment Group
Linden Advisors
Lazard Asset Management
Ovata Capital Management
Whitebox Advisors
BlackRock
SSI Investment Management
Lord, Abbett & Co
FMR
CSS
Bank of New York Mellon

View all funds holding Ptc Therapeutics